Director/PDMR Shareholding

RNS Number : 0641R

Reckitt Benckiser Group PLC

24 October 2019

 

                                                                                                            24 October 2019

RECKITT BENCKISER GROUP PLC

 DIRECTOR/PDMR SHAREHOLDINGS

Reckitt Benckiser Group plc (the "Company" or "RB") announces the following change in the interests of a Director in ordinary shares of 10 pence each in the share capital of the Company ("Shares").

The Company was notified on 23 October 2019 that Sara Mathew, Non-Executive Director, purchased a total of 378 American Depositary Receipts in the Company (ADRs) on 23 October 2019 at a price of $15.46 each. Five ADRs represent one Share.

The remuneration of RB's Non-Executive Directors includes fees which are to be used in the purchase of Shares or equivalent, e.g. ADRs. £16,750 of the Non-Executive Directors' base fee (net) is invested in Shares or equivalent which they are expected to retain for the duration of their tenure. The amount of Sara Mathew's fees applied in this way were pro-rated based on her appointment to the Board on 1 July 2019.     

The following disclosures are made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014. Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 1 Details of the person discharging managerial responsibilities / person closely associated a) Name Sara Mathew 2 Reason for the notification a) Position/status Non-Executive Director b) Initial notification/ Amendment Initial notification 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name Reckitt Benckiser Group plc b) LEI 5493003JFSMOJG48V108 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted a) Description of the financial instrument, type of instrument Identification code American Depositary Receipts (each American Depositary Receipt is equivalent to five Ordinary shares of 10 pence each in Reckitt Benckiser Group PLC) GB00B24CGK77 b) Nature of the transaction Purchase of shares c) Price(s) and volume(s) Price(s) Volume(s) $15.46 378 d) Aggregated information -       Aggregated volume -       Price Aggregate Price Aggregate Volume Aggregate Total $15.46 378 $5843.88 e) Date of the transaction 2019-10-23 f) Place of the transaction United States (OTC)

For further Information:
Christine Logan

Deputy Company Secretary
Tel [phone]

Richard Joyce

SVP, Investor Relations

Tel. [phone]

Reckitt Benckiser Group plc's LEI code is 5493003JFSMOJG48V108

About RB

RB* is a leading global health, hygiene and home company inspired by a vision of the world where people are healthier and live better. Its purpose is to make a difference by giving people innovative solutions for healthier lives and happier homes.

Through its two business units, Health and Hygiene Home, RB has operations in over 60 countries and its products reach millions of people globally every day. Its trusted household brands include names such as Enfamil, Nutramigen, Nurofen, Strepsils, Gaviscon, Mucinex, Durex, Scholl, Clearasil, Lysol, Dettol, Veet, Harpic, Cillit Bang, Mortein, Finish, Vanish, Calgon, Woolite and Air Wick.

RB's drive to achieve, passion to outperform and commitment to quality and scientific excellence is manifested in the work of over 40,000 diverse, talented entrepreneurs worldwide.

For more information visit www.rb.com

 *RB is the trading name of the Reckitt Benckiser group of companies

 

END

 

 

DSHBXBDGRDDBGCS